CopyFind
REDDY-NILOTINIB
medicine 📍 CA

REDDY-NILOTINIB

Analogs of REDDY-NILOTINIB

Find cheaper analogs and generic equivalents for REDDY-NILOTINIB.

Ingredients

Active Ingredient: NILOTINIB (NILOTINIB HYDROCHLORIDE MONOHYDRATE)


Product Overview

About REDDY-NILOTINIB

REDDY-NILOTINIB is a prescription medication containing the active ingredient Nilotinib Hydrochloride Monohydrate. It is used in the treatment of certain types of chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy, including imatinib.

Key Benefits & Uses

  • Treatment of CML with resistance or intolerance to prior therapy, including imatinib.
  • Targeted therapy to inhibit BCR-ABL tyrosine kinase activity.
  • May help manage disease progression and improve quality of life for patients with CML.

Active Ingredient & Action

Nilotinib Hydrochloride Monohydrate, the active ingredient in REDDY-NILOTINIB, is a tyrosine kinase inhibitor that specifically targets the BCR-ABL protein, which is responsible for the growth and survival of cancer cells in CML. By inhibiting this protein, Nilotinib Hydrochloride Monohydrate helps to slow or stop the growth of cancer cells, allowing the body's immune system to work more effectively.

Important Notes

REDDY-NILOTINIB should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully to minimize the risk of adverse effects. Patients with a history of pancreatitis, liver disease, or other medical conditions should inform their doctor before starting treatment with REDDY-NILOTINIB.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.

Similar Products & Analogs

Tasigna

Active: nilotinib

Match: 100% Compare →
ТАСИГНА

Active: Nilotinib

Match: 100% Compare →
Cavhanza

Active: Nilotinib

Match: 100% Compare →
НІЛОТИНІБ

Active: Nilotinib

Match: 100% Compare →
НІЛОТИНІБ-ВІСТА

Active: Nilotinib

Match: 100% Compare →
Nilotinib Accord

Active: nilotinib

Match: 100% Compare →